Publication | Closed Access

Safety of Glucagon-Like Peptide-1 Receptor Agonists: A Real-World Study Based on the US FDA Adverse Event Reporting System Database

Drug SafetyMolecular PharmacologyGlucagon-like Peptide-1 ReceptorAdverse EventPharmacologyClinical TrialsPharmacotherapyReal-world StudyMedicineAdverse Drug ReactionPharmacoepidemiology